1. Chromosome 1
   Ravi Gor et al, 2023, Cancer Genes CrossRef
2. ZYZ384 suppresses the growth of EGFR‐mutant non‐small cell lung cancer by activating JNK/MAPK signaling pathway
   Xiao‐Wen Nie et al, 2024, Chemical Biology & Drug Design CrossRef
3. Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
   Linxiang Zhang et al, 2024, Frontiers in Oncology CrossRef
4. Clinicopathological and Prognostic Significance of SMYD3 in Human Cancers: A Systematic Review and Meta-analysis
   Xuan Wang et al, 2022, Genetic Testing and Molecular Biomarkers CrossRef
5. Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3
   Marco Daniele Parenti et al, 2022, European Journal of Medicinal Chemistry CrossRef
6. SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer
   Donghui Liu et al, 2023, Journal of Oncology CrossRef
7. SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis
   Yingxue Zhang et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef
8. SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription
   Tian Tian et al, 2022, Cell Death & Disease CrossRef
9. Epigenetic therapy in lung cancer
   Michael Conroy et al, 2023, Epigenetic Cancer Therapy CrossRef
10. Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis
    Mahdieh Razmi et al, 2022, Expert Review of Molecular Diagnostics CrossRef
11. SMYD3 regulates the abnormal proliferation of non-small-cell lung cancer cells via the H3K4me3/ANO1 axis
    Dian Zhong et al, 2022, Journal of Biosciences CrossRef
12. Functions of SMYD proteins in biological processes: What do we know? An updated review
    Ascensión Rueda-Robles et al, 2021, Archives of Biochemistry and Biophysics CrossRef
13. Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC
    Xinlin Liang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
14. Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
    Alyssa Padilla et al, 2023, Molecules CrossRef
15. Epigenetics of cisplatin resistance
    Anne-Marie Baird et al, 2023, Epigenetic Cancer Therapy CrossRef
16. The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer
    Yaguang Zhang et al, 2023, International Journal of Molecular Sciences CrossRef
17. Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
    Liu Yang et al, 2021, Biology CrossRef
18. SMYD3: a regulator of epigenetic and signaling pathways in cancer
    Benjamin J. Bernard et al, 2021, Clinical Epigenetics CrossRef